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Cytotoxic effects of caffeic acid phenethyl ester
(CAPE) on the human multiple myeloma cell line*,**
Aim: Caffeic acid phenethyl ester (CAPE) has cytotoxic, apoptotic, and antiproliferative effects on
various tumor cells, and is the most active component of propolis. This study aimed to examine the
in vitro effects of CAPE on the human multiple myeloma cell line.
Materials and methods: CAPE was added to the ARH-77 multiple myeloma cell line and the
percentage of dead cells was measured using the 3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-SHtetrazolium bromide (MTT) assay. The percentage of live cells and growth inhibition were
determined using the Trypan blue test. The percentage of IL-6 cells was determined using ELISA.
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Results: ARH-77 cells treated with CAPE for 72 h at the 100 μg mL−1 concentration resulted in a
growth inhibition effect of 90.4% and a cytotoxic effect of 80.4%. CAPE induced apoptosis in 92.3%
of the cells in 22.5 μg mL−1 at 72 h. CAPE inhibited the secretion of IL-6 by ARH-77 multiple
myeloma cells at LD50 concentrations.
Conclusion: CAPE inhibited growth and secretion of IL-6, and induced apoptosis in a dosedependent and time-dependent manner in ARH-77 multiple myeloma cells. We think that CAPE
merits further study as an effective agent against multiple myeloma.
Key words: Caffeic acid phenethyl ester (CAPE), multiple myeloma, cytotoxicity, IL-6

Kafeik asit fenetil esterin (CAPE) insan multiple myleoma hücre
dizileri üzerinde sitotoksik etkiIeri
Genel bilgiler: Kafeik asit fenetil ester (CAPE), çeşitli tümör hücreleri üzerinde sitotoksik, apopitotik
ve antiproliferatif etkilere sahip propolisin en aktif bileşiğidir. Bu çalışma da ilaç direnci ve nükslerin
çok sık olarak görülmesine bağlı olarak tam bir tedavinin yapılamadığı insan multiple myeloma
hücrelerinde CAPE’nin etkilerini inceledik.
Yöntem ve gereç: CAPE, ARH-77 multiple myeloma hücre dizileri üzerine konuldu ve 3-(4,5dimethyl-thiazoyl)-2,5-diphenyl-SH-tetrazolium bromide (MTT) yöntemi ile ölen hücrelerin
yüzdeleri ölçüldü. Yaşayan hücrelerin yüzdesi ve büyüme inhibisyonu, trypan blue testi ile tespit
edildi. Hücrelerin IL-6 düzeyi yüzdesi ELISA ile hesaplandı.
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Bulgular: ARH-77 hücrelerine 72. saat ve 100 μg mL−1 konsantrasyonunda uygulanan CAPE, % 90.4
büyüme inhibisyonu ve %80.4 sitotoksik etki oluşturdu. CAPE’nin, 72. saatte ve 22,5 μg mL−1
konsantrasyonunda hücrelerin % 92,3’ünde apoptozisi indüklediği, LD50 konsantrasyonunda ARH77 hücreleri tarafından salınan IL-6 sekresyonunu inhibe ettiği bulundu.
Sonuç: CAPE’nin ARH-77 multiple myeloma hücreleri üzerinde doz ve zamana bağlı olarak büyüme,
IL-6 sekresyonunu inhibe ettiğini ve apoptozisi indüklediğini bulduk. CAPE’nin multiple myelomaya
karşı etkin bir ajan olarak ileriki çalışmalarda aday olabileceğini düşünmekteyiz.
Anahtar sözcükler: Kafeik asit fenetil ester, multiple myeloma, sitotoksitite, IL-6

* This study was presented as a poster at the 11th Congress of the Balkan Military Medical
Committee, 18-22 June 2006, Athens, Greece.
** This study was supported by a research grant from the Gülhane Medical Faculty Research Center.
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Introduction
Multiple myeloma (MM) is characterized by the
presence of malignant plasma cells or plasma blasts
localized predominantly in the bone marrow.
Interleukin-6 (IL-6) is a growth factor for human
myeloma cell lines. MM cannot be completely cured
due to the high frequency of relapse and drug
resistance. The uniformly fatal outcome of MM
warrants development of novel biologically based
treatment strategies that selectively induce apoptosis
in malignant plasma cells (8,9). Recently, several
agents, including curcumin, PS341, and thalidomide,
have been tested in the search for a more effective
treatment of MM. Nonspecific drug toxicity is one of
the major problems in cancer drug treatment (10).
Propolis, known as bee glue, is a sticky substance
that is dark-brown to yellow, depending on its origin.
It is a resinous and waxy substance that bees collect
from the buds and bark of trees (1). It has been
reported that propolis has antibacterial and antifungal
properties, and has been used by humans since early
times for various purposes (1-3). Greenaway et al.
identified 150 compounds in just 1 propolis sample
(4); however, in total, more than 300 have been
isolated to date. Progressive studies have shown that
propolis has antimicrobial, anti-inflammatory,
hepatoprotective, and anti-oxidative properties, and
stimulates the immune system. Caffeic acid phenethyl
ester (CAPE), which has anti-tumor, antiinflammation, antiviral action, and antioxidant
properties, is the most active component in propolis.
CAPE has cytotoxic, apoptotic, and antiproliferative
effects on various tumor cells, both in vivo and in
vitro (5-7).
The present study aimed to investigate the ability
of CAPE to induce apoptosis in the human MM cell
line.
Materials and methods
Cell line
The immunoglobulin G-secreting plasma cell
leukemia ARH-77 and λ light chain-secreting human
MM cell line were generously supplied by the
Karolinska Institute, Department of Hematology,
Huddinge, Sweden. ARH-77 cells were maintained in
864

Turk J Med Sci

RPMI 1640 medium supplemented with 10% and
20% heat-inactivated fetal calf serum, respectively,
−1
and 2 mM L-glutamine, 100 μg mL of streptomycin,
−1
and 100 U mL of penicillin at 37 °C in a 5% CO2
atmosphere.
3-(4,5-Dimethyl-thiazoyl)-2,5-diphenyl-shtetrazolium bromide assay (MTT)
The MTT assay was performed as previously
5
−1
described (11). Target tumor cells (1 × 10 cells mL )
were resuspended in medium after verification of cell
viability using the Trypan blue dye exclusion assay.
Then 100 μL of cell suspension was distributed into
each well of 96-well microtiter plates (Costar,
Cambridge, MA, USA), and each plate was incubated
for 24 h. Purified CAPE (≥99%) was purchased from
Sigma Chemical Co. (St. Louis, MO, USA) and
dissolved in DMSO (stock solution). Thereafter, 100
μL of reagent solution at the desired concentration (1,
−1
5, 10, 25, 50, or 100 μg mL ) with a final DMSO
concentration of 0.1% was distributed into each well
and treated for 24, 48, and 72 h. Wells containing 200
μL of medium alone, without cells or reagents, were
used as negative controls. Following treatment for the
stated incubation times, 20 μL of MTT solution (5 mg
−1
mL ) was added to each well and the microplates
were incubated for an additional 4 h at 37 °C. The
unreactive supernatants in the well were discarded,
and 100 μL of acidified isopropanol (0.04 N HCl in
isopropanol) was added to the cultures and mixed
thoroughly to dissolve the dark blue crystals of
formazan. The absorbance value (A) of each well was
determined with a microplate reader equipped with a
570-nm filter. The negative control well was used for
baseline zero absorbance. Results are presented as the
percentage of cytotoxicity, which was determined as
follows: 1-A of experimental well/A of positive control
well × 100. We calculated the dose of CAPE required
to kill 50% (LD50) of ARH-77 MM cells at 24, 48, and
72 h as a preliminary result for an animal study. Each
experiment was repeated 3 times, with representative
data presented.
DNA fragmentation assay
DNA fragmentation is one of the markers for
induction of apoptosis (12). Cells were treated with
different concentrations of CAPE for 24, 48, and 72
h. All the cells were harvested via centrifugation and
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lysed with lysis buffer (5 mM Tris-HCl at pH 8.0, 20
mM EDTA, and 0.5% Triton X-100) on ice for 60 min.
Cells were centrifuged at 14,000 rpm (45 min at 4 °C)
and the supernatant fraction was transferred to a new
tube. Then the quantity of protein was measured and
the same amount of protein was used to normalize
each sample for DNA fragmentation analysis.
Fragmented DNA in supernatant fractions was
extracted twice with phenol/chloroform/isoamyl
alcohol (25:24:1) and once with chloroform, and
precipitated with 100% ethanol and 5 M NaCl. The
DNA pellet was washed once with 70% ethanol and
resuspended in TE (10 mM Tris-HCl at pH 8.0, 1 mM
EDTA at pH 8.0) buffer (pH 8.0) with 100 μg mL−1 of
RNase A (Sigma) at 37 °C for 2 h. The DNA fragments
were separated by 1.8% agarose gel electrophoresis
and examined under ultraviolet light.
Cell growth kinetic
Cells were harvested after treatment with different
concentrations of CAPE for 24, 48, and 72 h. The
numbers of viable cells were counted using the Trypan
blue dye exclusion test. Growth inhibition was
calculated using the following equation: (cell number
in the control group – cell number in treated
group)/cell number in the control group. Each
experiment was repeated 3 times, with representative
data presented.
Assessment of apoptosis using an annexin-V FITC
apoptosis kit
The LD50 concentration of CAPE caused a
stimulating effect on apoptosis with the annexin V
method via flow cytometry. The cells were treated and
harvested as above. An annexin-V FITC apoptosis kit
(Oncogene Research Products, Cambridge, MA,
USA) was used to assess apoptosis, and then cells were
immediately analyzed by flow cytometry. Early
apoptotic cells were localized in the lower right
quadrant of a dot-plot graph using annexin-V FITC.
Each experiment was carried out on 3 different
samples.
Detection of IL-6 by ELISA
The supernatants of the cells with and without
CAPE in LD50 concentration were collected and the
IL-6 level of these cells was detected by ELISA
(BioSource International); each experiment was
repeated 3 times.
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Statistical analysis
Results are expressed as mean ± standard error of
at least 3 experiments. Statistical comparisons were
based on Kruskal-Wallis regression analysis or
analysis of variance. Differences were considered
significant at P < 0.05. All statistical analyses were
carried out with SPSS v.12.0 software (SPSS, Inc.).
Results
The cytotoxic effect of various concentrations of
CAPE (1-100 μg mL−1) on the ARH-77 MM cell line
with MTT assay is shown in Table 1. There was not a
significant difference in the percentage of dead cells in
the 1 or 5 μg mL−1 concentrations at 24, 48, or 72 h,
whereas in the 10, 25, 50, and 100 μg mL−1
concentrations of CAPE at 24, 48, and 72 h the
statistical difference in the percentage of dead cells
was significant. The cytotoxic effect of CAPE was
observed on ARH-77 cells, depending on the
concentration and duration of application (Figure 1).
There was not a significant difference in the
percentage of viable cells in the 1, 5, 10, 50, or 100 μg
mL−1 concentrations of CAPE at 24, 48, or 72 h,
whereas the decrease in viable cells in the 25 μg mL−1
CAPE concentration at 24, 48, and 72 h was
statistically significant (P = 0.002) (Table 2). Also, a
significant statistical difference was observed in the
25 μg mL−1 CAPE concentration between hours (2448 h: P = 0.045; 24-72 h: P = 0.001; 48-72 h: P = 0.007).
At 72 h it was obvious that the number of viable cells
decreased as the CAPE concentration increased
(Figure 2).
Table 1. MTT assay-based evaluation of the cytotoxic effect of
CAPE on ARH-77 MM cells at various concentrations
applied for 24, 48, and 72 h.
Concentrations
−1
(μg mL )

24 h
(%)

48 h
(%)

72 h
(%)

P

1

1.1

10.1

15.0

0.109

5

3.0

27.2

18.6

0.117

10

3.5

29.7

39.0

0.015

25

9.3

44.3

58.7

0.001

50

63.0

77.4

78.3

0.001

100

65.7

79.4

80.4

0.001
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Figure 1. A graph of the percentage cytoxicity of CAPE on the
ARH-77 cells in various concentrations at 24th, 48th
and 72nd hour. The data depict the mean ± SD of 3
separate experiments.
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Figure 2. The effect of increased CAPE concentrations on the
viability of ARH-77 human MM cell cultures is shown.
Table 3. The LD50 of CAPE at 24, 48, and 72 h.

Table 2. Evaluation of the percentage of viable ARH-77 MM cell
cultures after the application of CAPE at different
concentrations for 24, 48, and 72 h, based on the Trypan
blue viability test.
Concentrations
(μg mL−1)

24 h
(%)

48 h
(%)

72 h
(%)

P

1
5
10
25
50
100

94.5
87.0
85.2
69.3
30.8
17.5

91.1
88.7
83.7
49.1
13.7
4.3

91.6
72.5
64.3
26.5
9.8
3.7

0.480
0.053
0.118
0.002
0.293
0.098

CAPE was applied to ARH-77 human MM cells
(1, 5, 10, 25, 50. and 100 μg mL−1 concentrations) and
the percentage of dead cells was determined after 24,
48, and 72 h. The LD50 values of CAPE at 24, 48, and
72 h are shown in Table 3. With increased duration of
treatment the LD50 decreased.
Microscopic analysis of cell cultures to which
CAPE was applied for 24, 48, and 72 h showed
apoptotic changes, such as membrane blebbing and
cell fragmentation into apoptotic bodies (Figure 3).
At later times few surviving cells were observed.
The effect of treating cells with a CAPE LD50
concentration was measured using anexin V and flow
cytometry (Figure 4). CAPE induced apoptosis in
57.7% of the myeloma cells at the LD50 concentration
of 49.1 μg mL−1 at 24 h, 84.9% of the cells at 30.6 μg
mL−1 at 48 h, and 92.3% of the cells in 22.5 μg mL−1 at
72 h (Table 4).
866

Time

LD50 values

R

24

49.1

.874

48

30.6

.895

72

22.5

.827

The supernatants of the cells with and without an
LD50 concentration of CAPE were collected and the
concentration of IL-6 was detected by ELISA. At 24 h
−1
untreated cells expressed 15.9 pg mL of IL-6,
whereas treatment with CAPE lowered this level to
−1
13.6 pg mL at the LD50 concentration of 49.1 μg
−1
mL . Likewise, CAPE treatment lowered IL-6
−1
−1
secretion from 38 pg mL to 31.2 pg mL at 48 h and
−1
−1
from 73.5 pg mL to 15.6 pg mL at 72 h (Table 4). As
a result, LD50 concentrations of CAPE inhibited
secretion of IL-6 by ARH-77 MM cells at the
following percentages: 12.9% at 24 h, 17.9% at 48 h,
and 78.8% at 72 h (Figure 5).
DNA gel electrophoresis, which shows DNA
fragmentation, is a very effective way to distinguish
apoptosis from necrosis. This method is used in
almost every study to evaluate the apoptotic effect of
CAPE. In order to detect the effect of CAPE on
myeloma cells, DNA of the cells treated with/without
CAPE at LD50 concentration was subjected to 1.8%
agarose gel electrophoreses. The DNA of the cells
exposed to CAPE was fragmented at about 180-200
bp, which is consistent with cells undergoing
apoptosis (Figure 6).
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Figure 3. The microscopic views of MM cell culture with and without CAPE at
concentrations at the 24th, 48th and 72nd hour (40X). (I. Control, II. 24th hour,
III. 48th hour, IV. 72nd hour; N: Normal MM cell, A: Apoptotic MM cell, B:
Apoptotic Bodies).

(A)

(B)

(C)

(D)

Figure 4. Measurement of the apoptosis stimulating effect of CAPE in LD50 concentrations at the 24th, 48th and 72nd hour with Annexin
V method by flow cytometry (A: Control, B: 24 hours with 49.1 μg/mL, C: 48 hours with 30.6 μg/mL, D: 72 hours 22.5 μg/mL).
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Table 4. Evaluation of the inhibition of IL-6 secretion by ARH-77 MM cells due to CAPE at LD50 concentrations at 24, 48, and 72 h.
Time

LD50 values

Control cell
−1
IL-6 (pg mL )

With CAPE cell
IL-6 (pg mL−1)

IL-6 inhibition
(%)

24
48
72

49.1
30.6
22.5

15.6
38.0
73.5

13.6
31.2
15.6

12.9
17.9
78.8

80
70
Control
Secretion of IL-6 (pg/mL)

60

CAPE

50
1000 bp

40

500 bp

30

300 bp
20

200 bp
100 bp

10
0

24

48
Hours

72

Figure 5. Evaluation of inhibition secretion of IL-6 by ARH-77
multiple myeloma cells, at LD50 concentrations
according to hours.

Discussion
Recent studies show that CAPE has a strong
cytotoxic effect on various tumor cell lines and that it
has anti-oxidative properties (5-7,13-25). There have
not been any studies on the cytotoxic effect of CAPE
on MM cells, which are resistant to treatment.
Inhibition of apoptosis is a very important
mechanism of tumor formation and can cause
resistance to chemotherapeutic drugs. Many
chemotherapeutic agents may act via the induction of
apoptosis to block the carcinogenic process. It is
emphasized that the anti-tumor activity of CAPE
results from the induction of apoptosis (14). When
compared to other chemotherapeutic agents, an
advantage of CAPE is that it is 100% natural, as it is a
component of propolis, which is collected by bees
868

Figure 6. Induction of DNA fragmentation in ARH-77 MM cells
by CAPE in the LD50 concentrations at 24th, 48th and
nd
72 hour (Lane 1, 100-bp DNA ladder, lane 2, 24 h, lane
3, 48 h, lane 4, 72 h, lane 5, untreated cells).

from the bark and buds of trees. Studies show that
propolis has no side effects, except for slight allergic
reactions, and is not toxic to normal cells (26).
The cytotoxity rates and LD50 values we observed
were much higher than previously reported for
different cancer cells. Only the cytotoxity rate on
prostate cancer cells reported by McEleny et al. (22)
was similar to the cytotoxity rate of CAPE at 24 h in
the present study. We think that this similarity is a
result of the high resistance of both PC-3 prostate
cancer cells and ARH-77 cells to cytotoxity and
apoptosis.
CAPE not only inhibits tumoral cell growth due to
its antioxidant effect, but also induces apoptosis in
tumoral cells due to its cytotoxic properties. Chen et
al. (6) reported that CAPE induced growth inhibition
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in 70.3% and induced apoptosis in 41.7% of human
leukemic HL-60 cells via selective scavenging of
hydrogen peroxide, mitochondrial dysfunction, and
intracellular glutathione (GSH) depletion. We also
detected that the growth inhibiting effect of CAPE
was stronger than its cytotoxic effect.
Chen et al. (13) reported such results in a study
they performed on A549 human lung
adenocarcinoma cells. In many other studies, as in
ours, the annexin V method by flow cytometry was
used to test the apoptosis-stimulating effect of CAPE
on cancer cells (6,13,22-25). Most of the apoptosis
rates in various tumor cells were similar.
Dysregulation of the apoptotic mechanism in
plasma cells is considered a major underlying factor in
the pathogenesis and subsequent chemoresistance in
MM. IL-6 plays an important role in the progression
of MM malignancy by regulating the growth and
survival of tumor cells. Studies have shown that
secretion of IL-6 leads to expression of high levels of
anti-apoptotic proteins, such as protein B-cell
lymphoma-xL (Bcl-xL) and that over-expression of this
protein is a very important characteristic of MM cell
lines. Additionally, in MM cells IL-6 functions as an
osteoclast activator. It has been shown that the level
of IL-6 is related to disease activity. IL-6 is produced
in either an autocrine or paracrine manner (10,27).
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As mentioned above, we observed that CAPE
inhibited secretion of IL-6 by ARH-77 MM cells at
LD50 concentrations, with the following percentages:
12.9% at 24 h, 17.9% at 48 h, and 78.8% at 72 h. Some
researchers reported that there must be interaction
between bone marrow stromal cells and malignant
plasma cells for the production of IL-6 (27,28);
however, Alsina et al. (9) showed that there was no
IL-6 in the sera or bone marrow plasma cells of MMinfected mice, but that ARH-77 MM cells secreted 120
−1
mg mL of IL-6 in vitro. In the present study we
−1
noted that ARH-77 MM cells secreted 15.6 pg mL
−1
of IL-6 at 24 h, 38 pg mL of IL-6 at 48 h, and 73.5 pg
−1
mL of IL-6 at 72 h.
Consequently, we think that CAPE could be used
to treat MM in the future, because of its ability to
inhibit human ARH-77 MM cell growth and induce
apoptosis. Further research is needed to confirm this
hypothesis.
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